Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8998590 | 0.97 | PNMT (0.35) | PNMTNPC1RAB9APGRHTR2A | |
| Hydrochloric Acid SCHEMBL6557621 | 0.96 | PNMT (0.35) | PNMTNPC1RAB9APGRHTR2A | |
| SCHEMBL3373312 | 0.96 | PNMT (0.36) | PNMTNPC1RAB9APGRHTR2A | |
| SCHEMBL8775938 | 0.93 | PNMT (0.38) | PNMTNPC1RAB9APGRHTR7 | |
| SCHEMBL8776111 | 0.85 | PNMT (0.35) | PNMTNPC1RAB9APGRHTR7 | |
| SCHEMBL7582386 | 0.76 | PGR (0.40) | PGR | |
| SCHEMBL6470854 | 0.76 | PGR (0.40) | PGR | |
| SCHEMBL7575272 | 0.74 | PGR (0.38) | PGR | |
| SCHEMBL7572521 | 0.72 | — | — | |
| SCHEMBL7571267 | 0.72 | TDP2 (0.37) | PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0955305-B1 | Metallocene compound, and process for preparing polyolefin by using it | MITSUI CHEMICALS INC (JP) | 2005-10-26 | — | — | EP | disclosed |
| US-20020019504-A1 | Stereospecific; low molecular weight | MITSUI CHEMICALS, INC. (JP) | 2002-02-14 | — | — | US | disclosed |
| US-6342568-B1 | ADDITION POLYMERIZATION OF HIGHLYS STEREOSPECIFIC AND LOW MOLECULAR WEIGHT POLYOLEFINS USING CATALYST COMPRISING CYCLOPENTADIENYL-SUBSTITUTED FLUORENE COMPOUND COMPLEXED WITH GROUP IV METAL | MITSUI CHEMICALS, INC. (JP) | 2002-01-29 | — | — | US | disclosed |
| EP-0955305-A1 | Metallocene compound, and process for preparing polyolefin by using it | Mitsui Chemicals, Inc. (JP) | 1999-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019504-A1 | Stereospecific; low molecular weight | RPLP1, RPS4Y1, POLA1 | PNMT 2331/4885NPC1 3457/4885RAB9A 4326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.